Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Camphikefish on Dec 18, 2022 2:58pm

Happy Sunday

I have to say, there are many things I can not wrap my head around either. Many of these were just mentioned. Mostly though please suffice it to say more transparency is needed however, perhaps there's a strategy we do not yet understand behind this "close to the vest" stance Roger has taken. I'm old enough to know if this comes to fruition like we all desire it to, all of our concerns will be put to rest with just one news release. Just one news release to change all of our lives. What a ride this has been. My goodness what 1433 success could mean for patients and each one of us. I dream about it daily. Also, today I am proud to be part of this board for 2 reasons mainly. One is because I feel blessed to learn from each of you and as we in North Carolina, "for cryin out loud" you guys are super smart and expert researchers! (SF). The second reason is lately everyone disagrees like gentlemen and each learns from the other. Lastly, Please for the fun of it tell me this stock will get to 12.50 so I can hang up the cleats! Do you all think we'll get there for real or am I just dreaming? I just wonder if the Venture exchange is capable of such a run into those numbers. Be easy on me. Good day to all
Comment by 99942Apophis on Dec 18, 2022 5:32pm
Camphikefish the reason I started to do the "rough" calculations on possible share prices was of the enormous revenue Theralase will capture out of current NMIBC market. I don't understand if my fellow shareholders know how to calculate a share price or if they brush it off as pumping or just dreaming.  A $12.50 is very very attainable very quickly after AA & BTD alone or ...more  
Comment by Camphikefish on Dec 18, 2022 7:45pm
Thank you 99942Apophis. Music to my ears. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250